Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient [2]

AIDS

Volumn 17, Issue 11, 2003, Pages 1710-1711

  Atzori, Chiara ^a   Villani, Paola ^b   Regazzi, Mario ^b   Maruzzi, Massimiliano ^a   Cargnel, Antonietta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE;

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LUNG LAVAGE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LUNG; MALE; PYRIMIDINONES;

EID: 0042628225     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307250-00022     Document Type: Letter

References (8)

1. Morris A, Wachter RM, Luce J, Turner J, Huang L. Improved survival with highly active antiretroviral therapy in HIV infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17:73-80.
2. Atzori C, Angeli E, Mainini A, Agostoni F, Micheli V, Cargnel A. In vitro activity of HIV-1 protease inhibitors against P. carinii. J Infect Dis 2000; 181:1629-1634.
3. Atzori C, Cargnel A. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii. J Infect Dis 2002; 185:1692-1693.
4. Atzori C, Valerio A, Fantoni G, Tronconi E, Cargnel A. Effect of LPV/r and atazanavìr on P. carinii in vitro growth. In: 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2002 [Abstract M1157] p. 400.
5. Walzer PD, Ashbaugh A, Collins M, Cushion MT. Anti human immunodeficiency drugs are ineffective against Pneumocystis carinii in vitro and in vivo. J Infect Dis 2001; 184:1355-1357.
6. Conte J, Duncan S, McKenna E, Zurlinden E. Effect of gender and race on the pharmacokinetics of pentamidine in HIV-infected patients. Clin Pharmacokinet 1999; 17:293-299.
7. Khoo S, Hoggard P, Williams J, Meaden R, Newton P, Wilkins E, et al. Intracellular accumulation of human immunodeficiency virus protease inhibitors. Antimicrob Agents Chemother 2002; 46:3228-3235.
8. Andrè P, Groettrup M, Klenerman P, DeGiuli R, Booth B, Cerundolo V, et al. An inhibitor of HIV PIs modulates the proteasome activity, antigen presentation and T cell response. Proc Natl Acad Sci U S A 1998; 95:13120-13124.